ALSO NOTED: Nautilus files IND; Inforsense raises $10M; and much more...

> Nautilus Biotech has filed an IND for injectable Belerofon, its protease-resistant, long-lasting Interferon alpha. Release

> Inforsense has gained $10 million from investors. Release

> Theravance has released additional positive data from its Phase III trial of Telavancin for infections caused by Gram-positive bacteria. Release

> Schering-Plough has sued GeoPharma in a patent infringement case involving a copycat version of Clarinex. Report

> Daiichi Pharmaceutical has signed an agreement to acquire 100 percent of shares in Daiichi Pharmaceutical Korea. Release

And Finally… A viral disease has been sweeping through southern India and is being carried around the world by travelers. Article